Journal article icon

Journal article

From the genetics of ankylosing spondylitis to new biology and drug target discovery

Abstract:
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatments has been difficult due to the following challenges: 1) difficulties in determining the causal genes regulated by disease-associated SNPs, 2) difficulties in determining the relevant cell-type(s) that causal genes exhibit their function(s), 3) difficulties in determining appropriate cellular contexts to interrogate the functional role of causal genes in disease biology. This review will discuss recent progress and unanswered questions with a focus on these challenges. Additionally, we will review the investigation of biology and the development of drugs related to the IL-23/IL-17 pathway, which has been partially driven by the AS genetics, and discuss what can be learned from these studies for the future functional and translational study of AS-associated genes.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fimmu.2021.624632

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Botnar Research Centre
Oxford college:
Worcester College
Role:
Author
ORCID:
0000-0003-1503-6017


Publisher:
Frontiers Media
Journal:
Frontiers in Immunology More from this journal
Volume:
12
Article number:
624632
Publication date:
2021-02-17
Acceptance date:
2021-01-22
DOI:
ISSN:
1664-3224


Language:
English
Keywords:
Pubs id:
1158845
Local pid:
pubs:1158845
Deposit date:
2021-01-27
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP